Apodaca Jennifer, Kim Ikjin, Rao Hai
Institute of Biotechnology, Department of Molecular Medicine, The University of Texas Health Science Center, San Antonio, 78245, USA.
Biochem Biophys Res Commun. 2006 Aug 18;347(1):319-26. doi: 10.1016/j.bbrc.2006.06.078. Epub 2006 Jun 21.
Secretory proteins undergo a stringent quality control process in the endoplasmic reticulum (ER). Misfolded ER proteins are returned to the cytosol and destroyed by the proteasome. Prion protein PrP is degraded by the proteasome in mammalian cells. However, the significance of proteolysis on PrP-induced cell death is controversial. Moreover, the specific pathway involved in PrP degradation remains unknown. Here, we demonstrate that the unglycosylated form of human PrP is subjected to the ER-associated protein degradation (ERAD) process in the yeast Saccharomyces cerevisiae. We also show that unglycosylated PrP is degraded by the Hrd1-Hrd3 pathway. Accumulation of misfolded proteins triggers the unfolded protein response (UPR), which promotes substrate refolding. Interestingly, we find that the expression of PrP leads to growth impairment in cells deficient in UPR and ERAD. These findings raise the possibility that decreased UPR activity and proteolysis may contribute to the pathogenesis of some prion-related diseases.
分泌蛋白在内质网(ER)中经历严格的质量控制过程。错误折叠的内质网蛋白会被返回至胞质溶胶并被蛋白酶体降解。朊病毒蛋白PrP在哺乳动物细胞中被蛋白酶体降解。然而,蛋白酶解对PrP诱导的细胞死亡的意义存在争议。此外,PrP降解所涉及的具体途径仍不清楚。在此,我们证明人PrP的未糖基化形式在酿酒酵母中经历内质网相关蛋白降解(ERAD)过程。我们还表明未糖基化的PrP通过Hrd1-Hrd3途径降解。错误折叠蛋白的积累会触发未折叠蛋白反应(UPR),从而促进底物重新折叠。有趣的是,我们发现PrP的表达会导致缺乏UPR和ERAD的细胞生长受损。这些发现增加了一种可能性,即UPR活性降低和蛋白水解可能促成某些朊病毒相关疾病的发病机制。